Pfam Domains GO Terms
| Ets |
| BMP signaling pathway involved in mesodermal cell fate specification |
| regulation of transcription involved in primary germ layer cell fate commitment |
| positive regulation of mesoderm development |
| mesodermal cell fate specification |
| mesodermal cell fate commitment |
| positive regulation of endothelial cell differentiation |
| regulation of transcription involved in cell fate commitment |
| regulation of mesoderm development |
| mesodermal cell differentiation |
| cell fate commitment involved in formation of primary germ layer |
| regulation of endothelial cell differentiation |
| positive regulation of epithelial cell differentiation |
| mesoderm formation |
| mesoderm morphogenesis |
| erythrocyte differentiation |
| cell fate specification |
| erythrocyte homeostasis |
| BMP signaling pathway |
| blastocyst development |
| cellular response to BMP stimulus |
| response to BMP |
| myeloid cell homeostasis |
| formation of primary germ layer |
| mesoderm development |
| Notch signaling pathway |
| regulation of epithelial cell differentiation |
| placenta development |
| gastrulation |
| transmembrane receptor protein serine/threonine kinase signaling pathway |
| homeostasis of number of cells |
| myeloid cell differentiation |
| cell fate commitment |
| cell-cell signaling by wnt |
| Wnt signaling pathway |
| in utero embryonic development |
| blood vessel morphogenesis |
| reproductive structure development |
| cell surface receptor signaling pathway involved in cell-cell signaling |
| reproductive system development |
| DNA-binding transcription activator activity, RNA polymerase II-specific |
| blood vessel development |
| cellular response to growth factor stimulus |
| RNA polymerase II proximal promoter sequence-specific DNA binding |
| vasculature development |
| cardiovascular system development |
| response to growth factor |
| hemopoiesis |
| tissue morphogenesis |
| embryonic morphogenesis |
| hematopoietic or lymphoid organ development |
| chordate embryonic development |
| immune system development |
| embryo development ending in birth or egg hatching |
| tube morphogenesis |
| developmental process involved in reproduction |
| enzyme linked receptor protein signaling pathway |
| tube development |
| circulatory system development |
| anatomical structure formation involved in morphogenesis |
| positive regulation of cell differentiation |
| embryo development |
| cell-cell signaling |
| positive regulation of transcription by RNA polymerase II |
| cellular response to endogenous stimulus |
| positive regulation of developmental process |
| reproductive process |
| reproduction |
| response to endogenous stimulus |
| positive regulation of transcription, DNA-templated |
| DNA-binding transcription factor activity, RNA polymerase II-specific |
| positive regulation of nucleic acid-templated transcription |
| positive regulation of RNA biosynthetic process |
| homeostatic process |
| positive regulation of RNA metabolic process |
| tissue development |
| regulation of cell differentiation |
| positive regulation of nucleobase-containing compound metabolic process |
| positive regulation of macromolecule biosynthetic process |
| positive regulation of cellular biosynthetic process |
| positive regulation of gene expression |
| positive regulation of biosynthetic process |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Expression Distribution